0000899243-23-015817.txt : 20230616
0000899243-23-015817.hdr.sgml : 20230616
20230616191540
ACCESSION NUMBER: 0000899243-23-015817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NSV Partners III GP LLC
CENTRAL INDEX KEY: 0001889601
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 231022849
BUSINESS ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 2126885100
MAIL ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NSV Partners III LP
CENTRAL INDEX KEY: 0001890004
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 231022850
BUSINESS ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 2126885100
MAIL ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001890004
NSV Partners III LP
500 WEST PUTNAM AVENUE, SUITE 400
GREENWICH
CT
06830
0
0
1
0
0001889601
NSV Partners III GP LLC
500 WEST PUTNAM AVENUE, SUITE 400
GREENWICH
CT
06830
0
0
1
0
0
Common Stock
2023-06-14
4
S
0
50000
35.0757
D
9787045
I
See Footnotes
Represents the weighted average share price of an aggregate total of 50,000 shares sold in the price range of $35.00 to $35.5081. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of: (i) 5,286,971 shares held by NSV Investments I, LP, (ii) 1,037,831 shares held by NSV Investments III, LP, (iii) 374,756 shares held by NSV Master Limited Partnership II, LP, (iv) 320,831 shares held by NSV 2019 Opportunities Fund, LP, (v) 273,782 shares held by NSV 2018 New Horizons Fund, LP, (vi) 330,816 shares held by Life & Tech, (vii) 434,423 shares held by New Science Ventures, LLC, (viii) 967,609 shares held by NSV Partners III, LP, (ix) 279,748 shares held by NSV Investments II, LP, (x) 296,359 shares held by NSV Partners II, LLC, (xi) 53,466 shares held by NSV Growth Opportunities Fund, LP, (xii) 38,240 shares held by New Science Ventures Fund III, LP, (xiii) 33,610 shares held by NSV 2017 Opportunities Fund, LP, (xiv) 23,436 shares held by NSV 2018 Opportunities Fund, LP, (xv) 18,126 shares held by NSV 2016 Opportunities Fund, LP,
(Continued from Footnote 2): (xvi) 12,056 shares held by New Science Ventures Fund III (Offshore), LP, and (xvii) 4,985 shares held by NSV 2016 Opportunities Fund (Offshore), LP (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.
NSV Partners III, LP is the general partner of NSV 2018 New Horizons Fund, LP, NSV Investments I, LP, NSV 2018 Opportunities Fund, LP, NSV 2019 Opportunities Fund, LP, NSV Growth Opportunities Fund, LP, NSV Investments III, LP, and NSV Investments II, LP.
NSV Partners II, LLC is the general partner of New Science Ventures Fund III, LP, New Science Ventures Fund III (Offshore), LP, NSV 2016 Opportunities Fund, LP, NSV 2016 Opportunities Fund (Offshore), LP, NSV 2017 Opportunities Fund, LP, and NSV Master Limited Partnership II, LP.
Somasundaram Subramaniam is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, LP is general partner. Mr. Subramaniam is the majority member and managing member NSV Partners II, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners II, LLC is general partner. Mr. Subramaniam is the majority member and managing member of NSV Management, LLC, and may be deemed to share voting and dispositive power over the shares held by Life & Tech, for which NSV Management, LLC is the investment advisor. Mr. Subramaniam disclaims beneficial ownership over the shares owned by each of the NSV Funds, except to the extent of his pecuniary interest therein. Mr. Subramaniam is a director of the Issuer and files separate Section 16 reports.
/s/ NSV Partners III, LP, By: Brenda Marex, Chief Financial Officer
2023-06-16
/s/ NSV Partners III GP, LLC, By: Brenda Marex, Chief Financial Officer
2023-06-16